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ABSTRACT The f3 and y subunits of the heterotrimeric
guanine nucleotide binding (G protein) act as a dimer and
directly regulate various signal transduction pathways. By
using cotransfection assays, we tested the ability of several fty
combinations to activate inositol phospholipid-specific phos-
pholipase C (PI-PLC)-j82. Our findings indicate that only ,8ry
combinations that form dimers will activate PI-PLC-182. Since
Gj81 interacts with Gyl, while Gj82 cannot, chimeras between
G181 and G182 were used to identify the regions in i31 that
determine its specific association with yl. Our evidence
demonstrates that a chimera between j82 and 131 that contains
the C-terminal 173 amino acids of 131 can interact and activate
PI-PLC-f32 with yl. Chimeras that contain portions of the f31
C-terminal region display a weaker association with yl.
Furthermore, the contribution of each of these regions de-
pends on the sequence context of each chimeric protein.
However, the segment between residues 210 and 293 of 81
consistently plays a critical role in specifying association with 'yl.
Heterotrimeric guanine nucleotide binding proteins (G pro-
teins) transduce signals from cell surface receptors to a variety
of effector systems via a guanine nucleotide binding and
hydrolysis cycle. The Ga subunits activate second messenger-
generating systems (1-3). Furthermore, there is evidence that
f3y dimers also have an active role in signal transduction
pathways (4-6). Recent efforts have shown that the Goy dimer
can contribute to the selective coupling of the heterotrimeric
G protein to its receptor (7-9) and can regulate various
downstream effector systems such as adenylyl cyclase, inositol
phospholipid-specific phospholipase C (PI-PLC), the atrial
potassium channel, a cytosolic inositol phospholipid 3 kinase,
and mitogen-activated protein kinases (10-20). In addition,
G13y can facilitate the translocation of specific kinases to the
membrane (21, 22).
At present, five distinct 13 subunits have been cloned (23-
25), and there are at least seven different G-y subunits (23, 24,
26). Testing for the interaction between 13 and y subunits by
using cell-free and transfection systems has indicated that the
(31 subunit can interact with both yl and y2 subunits, whereas
(32 can interact with y2 and not with yl (27, 28). By using
purified recombinant 13y dimers, 131 has been found to dimer-
ize with yl, 'y2, y3, yS, and y7, whereas (32 can dimerize with
y2, 'y3, y5, and 'y7 but not with yl (29-31). Similar findings
came from transfection studies testing the ability of 13,y com-
binations consisting of 131 or 12 with yl, y2, or 'yS to activate
PI-PLC-,B2 (11, 32). The structural basis for the interactions
between the 1 and -y subunits has not been established.
Crosslinking experiments show that yl can interact with the N
terminus of 31 (33). Computer-assisted molecular modeling of
the j3 and y subunits revealed that their N-terminal regions can
form a-helical coiled-coil structures and it was postulated that
13 and y dimerize through these regions (34, 35). However, the
N-terminal coiled-coil structure cannot account, by itself, for
the exceptional stability of f3y dimers (36). Recently, Pronin
and Gautam (28) showed that yl does not bind 132 but binds
to a chimeric 132-131 protein containing the 59 N-terminal
residues of 132, indicating that sequences downstream of res-
idue 59 in 31 contribute to the stability and specificity of the
13lyl dimer. In the present study, by using the cotransfection
assay, we identified the region of the (1 subunit that deter-
mines its specific interaction with the yl subunit.
MATERIALS AND METHODS
cDNA Constructs and Transient Transfections into COS-7
Cells. The cDNAs were inserted into cytomegalovirus expres-
sion vectors as follows: G131 and Gy2 subunits were cloned into
pCDM8.1 (Invitrogen); PLC-,32 was inserted in pMT2; and the
G,yl mutant y1C71L with the Cys-71 -- Leu substitution was
introduced into pCIS. A bacterial ,B-galactosidase gene in pCIS
served as a transfection control. The chimeras between G13l
and G132 were constructed by synthesizing each corresponding
cDNA portion with the PCR. Both portions of the chimeric
cDNA were fused through a common restriction site that was
created by introducing silent mutations at the junction sites.
The common restriction endonuclease sites created were
BssHII, HindIII, Sal I, and Mun I at positions corresponding
to amino acids (aa) 167, 209, 250, and 293, respectively. Each
pair of synthesized fragments was digested with the corre-
sponding restriction enzymes and inserted between the Cla I
and Not I of pCIS. The sequence of the chimeric constructs was
verified by restriction enzyme analysis and DNA sequencing
using the Dye-Terminator method (Perkin-Elmer ABI) and
the 373A automated sequencer of ABI.
COS-7 cells were maintained in Dulbecco's modified Ea-
gle's medium (DMEM) containing 10% (vol/vol) fetal calf
serum. Approximately 1 X 105 cells per well were seeded in
12-well plates 1 day before transfection. The total amount of
DNA in all transfections was 0.9 ,ug per well. The amount of
each type of DNA in each set of experiments was equal and
pCIS encoding 3-galactosidase was used to maintain a con-
stant amount ofDNA. To each well, 0.9 ,ug ofDNA mixed with
5 Al of LipofectAmine (Bethesda Research Laboratories) in
0.5 ml of Opti-MEM (Bethesda Research Laboratories) was
added and 5 h later 0.5 ml of 20% fetal calf serum in DMEM
was added to the cells. Cells were assayed for inositol phos-
phate levels or harvested for protein expression analysis 48 h
after transfection.
Analysis of Inositol Phosphate Levels in Intact Cells. One
day after transfection, the medium was removed and the cells
were washed with phosphate-buffered saline (PBS) and incu-
bated in 0.4 ml of inositol-free DMEM with 10% dialyzed fetal
calf serum containing myo-[2-3H]inositol (NEN) at 10 ,uCi/ml
(1 Ci = 37 GBq). Twenty-four hours later, the cells were
Abbreviations: G protein, guanine nucleotide binding protein; Pl-
PLC, inositol phospholipid-specific phospholipase C.
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washed with PBS, 200 ,lI of inositol-free medium containing 10
mM LiCl was added, and the cells were incubated for 25 min
at 37°C. Each reaction was stopped by adding 200 ,ul of ice-cold
10% (vol/vol) perchloric acid and 20 ,ul of phytic acid (20
mg/ml) and incubating the cells on ice for 10 min. Then 200
,ul of the supernatant was transferred to a microcentrifuge tube
and neutralized with 2 M KOH. After centrifugation, the
supernatant was loaded on a 0.5-ml AG1-X8 anion-exchange
column (200-400 mesh, formate form, Bio-Rad). The sepa-
ration was done essentially as described by Berridge et al. (37)
and 0.5 ml of the eluted material was mixed with 10 ml of BCS
scintillation solution (Amersham) and radioactivity was mea-
sured. All the data represent duplicate determinations in a
single experiment. The error bar expresses the range of
duplicate samples. Three additional experiments gave similar
results. SDS/PAGE and Western blot analysis were done as
described (11).
RESULTS
Gl3 and Gf32 share 90% identity in their amino acid sequence,
yet G,Blyl activates PI-PLC-32, while G32,y1 does not. On the
other hand, both G31-y2 and GP2,y2 dimerize and activate
PI-PLC-f32 (11, 31, 32). To identify the region on Gl3 that
determines its specific interaction with Gyl, the activation of
PI-PLC-132 was used as the assay. A reciprocal series of
chimeras between Gf3l and Gf32 was generated and the ability
of these chimeras to presumably form dimers with Gyl and
activate PI-PLC-,32 in transfected COS-7 cells was tested. Two
chimeras were prepared, Chil, which encodes the N-terminal
167 aa of G/31, and Chi2, which encodes the first 209 aa of G,B1
(Fig. IA). As a control, we measured the expression levels of
transfected Chil and Chi2 and of the wild-type /31 and (32 and
found that all were expressed at roughly similar levels (Fig.
1B). Fig. 1C shows the levels of inositol phosphates released
by these Go3 subunit constructs when cotransfected with Gyl
and PI-PLC-f32 constructs. ,Blyl directed a very high level of
inositol phosphate release, whereas Chil'yl and Chi2,yl pro-
moted marginal increases and 32,yl did not direct any increase.
Since it is possible that the functional ability of the chimeric
proteins to activate PI-PLC-,B2 has been altered, an additional
control experiment was performed. This was done by cotrans-
fecting Chil, Chi2, ,31, or (2 with y2 (which can dimerize with
131 and (32 and activate PI-PLC-f32; data not shown) and
measuring the levels of inositol phosphates released in the
presence of transfected PI-PLC-/32. Fig. 1D demonstrates that
both chimeras are capable of activating PI-PLC-f32 very well
when expressed with y2. To address the possibility that the
chimeras can interact with yl but cannot activate PI-PLC-f32,
we tested for the direct interaction of the chimeras with yl by
measuring the translocation of Gf3 subunits from the mem-
brane fraction to the cytosol, based on the finding that in
transfected cells, ylC71L, a Gyl that cannot be isoprenylated,
will shift GP3 subunits that it can dimerize with from the
membrane fraction to the cytosol (28, 35). Fig. 1E shows that
coexpression of Chi2 and -y1C71L had very little or no effect
on the cellular distribution of Chi2. As control, we tested the
effect of the yl mutant on j1 and (32, and as expected, a
significant portion of G3l shifted to the cytosol but no shift in
G(32 was observed. These results indicate that Chil and Chi2
interact very weakly, if at all, with Gyl and suggest that the
N-terminal 209 aa of G1l are not sufficient to confer associ-
ation with G'yl.
Next, we tested the reciprocal series of chimeric GP32-Gf1
constructs containing an N-terminal sequence from G(2 and
a C-terminal sequence from G,Bl. The linear structures of the
chimeras are illustrated in Fig. 2A. The expression levels of the
chimeras and wild-type ,31 and /2 were found to be essentially
similar (Fig. 2B). Transfection of Chi3, which encodes the first
167 aa of G,B2 and the last 173 aa of G,B1 directed, a 5-fold
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FIG. 1. Structure and expression of the G,B1-,B2 series of chimeras
and their effect on PI-PLC-P2 activity in transfected COS-7 cells. (A)
Linear structures of G131-12 chimeras. (B) Immunoblot analysis of the
expression of G,B1, Chil, Chi2, and G,B2 in transfected cells. The Go3
subunits were detected with an antibody directed against the C-
terminal 15 aa that are identical in (31 and ,32 subunits. (C and D) The
effect of cotransfecting G/31, Chil, Chi2, or G/32 with either G-yl (C)
or Gy2 (D) on the activity of PI-PLC-f32 in COS-7 cells. DNAs
transfected are indicated for each bar. (E) Cellular localization of Gj31,
Chi2, or G,32 cotransfected with Gyl or with the -y1C71L mutant. Cells
were transfected with each cDNA at 0.45 ,ug per well. Transfected cells
were harvested, lysed, and fractionated to cytosolic and particulate
fractions (indicated by C and P, respectively). Equal volumes of both
fractions were resolved by gel electrophoresis and electroblotted.
cDNAs transfected are indicated above the blots, and yl* represents the
-y1C71L mutant. Blots were probed as described in B.
increase in the level of inositol phosphates when transfected
with Gyl and PI-PLC-(32 cDNAs (Fig. 2C). This suggests that
the C-terminal 173 aa of Gl3 are sufficient to endow the
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FiG. 2. Structure and expression of G,B2-,31 series of chimeras and
their effect on PI-PLC-P32 activity in transfected COS-7 cells. (A)
Linear structures of GP2-f31 chimeras. (B) Immunoblot analysis of the
expression of Gl31, Chi3, Chi4, Chi5, Chi6, and GP32 in transfected
cells. Blots were probed as in Fig. 1. (C and D) The effect of
cotransfecting G,B1, Chi3, Chi4, Chi5, Chi6, or G,32 with either Gyl
(C) or G-y2 (D) on the activity of PI-PLC-(2 in COS-7 cells. DNAs
transfected are indicated for each bar. (E) Cellular localization of Chi3
and Chi6 cotransfected with Gyl or with ylC71L. Cells were trans-
fected with each cDNA at 0.45 ,ug per well. Transfected cells were
harvested, lysed, and fractionated to a cytosolic and particulate
fractions (indicated by C and P, respectively). Equal volumes of both
fractions were resolved by gel electrophoresis and electroblotted.
cDNAs transfected are indicated above the blots, and -yl* represents
the ylC71L mutant. Blots were probed as described in B.
chimeric protein with the ability to associate with Gyl. To
delineate this region further, we tested additional chimeric
constructs containing shorter portions of ,B1 at their C-
terminal ends. Chi4, which harbors 131 residues of G131 at its
C-terminal end, was able to promote a 4-fold increase in the
level of inositol phosphates. Chi5, which contains the C-
terminal 90 residues of G131, directed weak increases in the
level of inositol phosphates. Chi6, which encodes only the last
47 aa of Gf3l, hardly raised the level of inositol phosphates.
Transfection of chimeras with Gy2 instead of Gyl directed a
large increase in the levels of released inositol phosphates (Fig.
2D), indicating that the chimeras have retained their ability to
activate PI-PLC-,32 provided that they can dimerize. These
findings imply that the reduced ability of Chi4, Chi5, and Chi6
to activate PI-PLC-,B2 when transfected with Gyl is probably
due to their reduced affinity for Gyl. To determine association
more directly, we tested the effect of the Gyl mutant ylC71L
on the cellular distribution of Chi3 and Chi6 in transfected
cells. Fig. 2E shows that ylC71L can translocate Chi3 to the
cytosol, whereas ylC71L has a barely detectable effect on the
localization of Chi6. These observations indicate that in our
assay system, there is a correlation between the ability to
activate PI-PLC-32 and the ability to dimerize with Gyl. The
ability of Chi4, which contains 131 residues of G,Bl at its
C-terminal end, to activate PI-PLC-f32 by 4-fold indicates that
the C-terminal 131 aa are essentially sufficient to confer on the
chimeric protein the ability to associate with G'yl. However,
the region between residues 168 and 209 of G,B1 may also
contribute to the interaction with Gyl since Chi3 activated
PI-PLC-j32 more efficiently than Chi4. The significantly re-
duced ability of Chi5 and Chi6 to activate PI-PLC-,B2 pinpoints
the region of G,B1 between aa 210 and 293, as essential in
determining the specific interaction of Gf3l with G-yl.
To further characterize the C-terminal region of G31,
double chimeric constructs were prepared and tested. This was
done by replacing portions of the C-terminal end of Chi3 with
the corresponding portions of Gf32 (Fig. 3A). The expression
levels of Chi7, Chi8, Chi9, 31, and (32 (Fig. 3B) are similar. The
inositol phosphate levels measured in cells cotransfected with
one of these chimeras, G-yl, and PI-PLC-,32 are depicted in
Fig. 3C. Chi7, which harbors the G,B1 sequence between aa 168
and 209, did not direct an increase in level of inositol phos-
phates. Chi8, which contains residues 168-250 of G1l, in-
creased the level of inositol phosphates by 2-fold. An increase
of almost 4-fold in the levels of inositol phosphates was
observed with Chi9, which contains the Gfl sequence from aa
168 to 293. When G-yl was replaced with Gy2 in transfections,
all of the chimeras retained their ability to activate PI-PLC-f32
(Fig. 3D). These findings demonstrate that Chi7 cannot acti-
vate PI-PLC-f32 when transfected with Gyl and indicate that
aa 168-209 of G,l are not sufficient for interaction with G'yl.
The ability of Chi8 and Chi9 to activate PI-PLC-f32 implies that
the region of G,B1 between residues 210 and 293 contains
elements that additively contribute to the specific interaction
of G,l with Gyl. This finding is consistent with the previous
result showing that chimeras lacking this region (ChiS and
Chi6) interact very weakly with yl (Fig. 2).
An additional two double chimeric constructs derived from
Chi4 were prepared and tested to further evaluate the contri-
bution of the region between residues 210 and 293 of 11; the
linear structures of the chimeras are shown (Fig. 4A). Trans-
fection of ChilO, which encodes aa 210-250 of Gf3l, directed
a marginal increase in the level of inositol phosphates when
transfected with Gyl and PI-PLC-32 cDNAs (Fig. 4C). Chill,
which harbors residues 210-293 of G131, when transfected with
G,yl induced a 2-fold increase in the level of inositol phos-
phates released in transfected cells. Both chimeras were able
to activate PI-PLC-P2 when transfected with Gy2 (Fig. 4D).
These observations suggest that aa 210-250 are not sufficient
to confer on the chimera the ability to associate with Gyl,
whereas a larger portion of G131, including aa 210-293, is
sufficient to specify dimerization with Gyl.
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FIG. 3. Structure and expression of G132(167)-031-f32 series of
chimeras and their effect on PI-PLC-j32 activity in transfected COS-7
cells. (A) Linear structures of G132(167)-f3l-032 chimeras. (B) Immu-
noblot analysis of the expression of Gf3l, Chi7, Chi8, Chi9, and G,B2
in transfected cells. Blots were probed as in Fig. 1. (C and D) The effect
of cotransfecting G,Bl, Chi7, Chi8, Chi9, or G,32 with either Gyl (C)
or G-y2 (D) on the activity of PI-PLC-,2 in COS-7 cells. DNAs
transfected are indicated for each bar. Transfection and analysis of
[3H]inositol phosphate levels were as described above.
DISCUSSION
Testing the ability of a series of chimeras between (31 and (32
to dimerize with -yl and activate PI-PLC-P2 has demonstrated
that regions in the C-terminal half of 131 determine its asso-
ciation with yl. Although the N-terminal part of 131 has been
implicated in its association with the y subunit, we found that
chimeras harboring up to 209 aa from the N-terminal end of
,11 interacted very weakly, if at all, with yl. On the other hand,
since all the chimeras and ,31 and (2 were able to dimerize with
y2, it is tempting to postulate that the N terminus although
associated with the -y subunit is not sufficient to determine
specificity for yl. Our assay for dimerization was based on the
observation that only 13y dimers can activate PI-PLC-12. All
chimeras were able to activate PI-PLC-12 with y2. Further-
more, we tested the association of several chimeric proteins
with -yl in a direct assay and found a correlation between the
ability of the chimeras to dimerize with yl and their ability with
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FIG. 4. Structure and expression of G132(210)-,13l-132 series of
chimeras and their effect on PI-PLC-,32 activity in transfected COS-7
cells. (A) Linear structures of G132(210)-,f1-032 chimeras. (B) Immu-
noblot analysis of the expression of G,Bl, ChilO, Chill, and G,B2 in
transfected cells. Blots were probed as in Fig. 1. (C and D) The effect
of cotransfecting G,Bl, ChilO, Chill, or G,32 with either G-yl (C) or
G-y2 (D) on the activity of PI-PLC-432 in COS-7 cells. DNAs trans-
fected are indicated for each bar.
-yl to activate PI-PLC-132. Our results clearly indicated that a
chimeric protein of 132-131 harboring the C-terminal 173 aa of
l31 (Chi3, Fig. 2) with yl was able to activate PI-PLC-,B2.
Chimeras that contain shorter portions of ,13 in their C
terminus directed less activation of PI-PLC-132. Chi4, which
contains only the last 131 residues of 131, was able to direct
-80% of the activation of PI-PLC-132. The contributions of aa
210-250 and 251-293 to the association with yl are important
since chimeras lacking these sequences (Chi5 and Chi6, Fig. 2)
directed very little activation of PI-PLC-,B2 when expressed
with yl. As seen in Fig. 5, 131 differs from P2 in the region of
aa 168-293 by 18 aa that are scattered along the sequence. Our
results show that residues 168-209 of 131 cannot confer asso-
ciation with
-yl (Chi7, Fig. 3). A chimera (Chi8) containing a
larger portion of 131, aa 168-250, showed 40% activation,
whereas a chimera harboring residues 168-293 directed 65%
of the activation observed with 131 (Chi9, Fig. 3). These
findings suggest that sequences in 131 between residues 210 and
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FIG. 5. Amino acid sequence comparison between Gl3 and Gf32.
Both sequences are aligned. Dots represent amino acid identity. The
arrows indicate the junction sites of the various chimeras and the
numbers mark the amino acid positions of the junction sites.
293 can confer on the chimera the ability to associate with yl.
The finding that Chi9 does not activate PI-PLC-f32 as well as
Chi3 (compare Fig. 3 to Fig. 2) indicates that the sequence
outside the region of aa 210-293 region stabilizes this region
and enhances its activity. Although, the region of aa 210-250
was found to contribute to the association with yl, this region
by itself cannot confer on ChilO association with yl. However,
even Chill, which includes the entire region but lacks the rest
of the f31 context, was able with -yl to direct only 40% of the
activation of PI-PLC-132 found with 3lyl, supporting the
suggestion that the segment from aa 210 to 293 is stabilized in
a specific active conformation in the context of the other (31
sequences. Interestingly, several mutations in the subunit of
yeast (ste4) that disrupted its ability to interact with the y
subunit (stel8) are located in this region (38). Some stretches
of amino acid sequence in the C-terminal half of (31 that
determine its association with yl may interact directly with yl,
while others may determine the conformation of the protein
and contribute indirectly to the association with yl.
Note Added in Proof. While this manuscript was under review, a paper
by Garritsen and Simonds (39) that arrived at similiar conclusions by
using different assay procedures appeared.
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